No image available
A squirt in the right direction for drugmakers?
Drugmakers’ traditional model is under threat from looming loss of exclusivity on some of the industry’s biggest sellers.
Drugmakers’ traditional model is under threat from looming loss of exclusivity on some of the industry’s biggest sellers.
Pfizer is buying rival drug maker Wyeth in a -billion deal that will increase its revenue by 50 percent and solidify its No 1 rank in the industry.
Pfizer Inc was close to a -billion purchase of US rival Wyeth in a move to diversify its revenue base, sources familiar with the situation said.